home.aspx
 
. https://biotechnology.report/Resources/Whitepapers/d3eba854-22bf-41b6-a7aa-4e70bd471339_Labiotech__Medpace_A-Toolkit-For-Emerging-Biotechs_White-Paper.pdf
whitepaper
SHARESHARESHARE
A TOOLKIT FOR EMERGING BIOTECHS
Emerging biotechs are a force to be reckoned with. In 2018, approximately 70% of clinical pipelines belonged to emerging biotechs, who were also responsible for nearly 64% of new active substances approved by the FDA. In other words, 38 out of 59 approved therapies were patented by emerging biotechs last year. These numbers prove that biotechs are leveling the playing field and are leading innovation in the drug discovery and development space. DOWNLOAD